Rabbit Polyclonal Epoxide hydrolase antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human EPHX1 aa 50-300.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
WB | IHC-P | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Cow | Predicted | Predicted | Predicted |
Pig | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Pig | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Pig | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/200.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Pig | Dilution info - | Notes - |
Select an associated product type
Biotransformation enzyme that catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols by the trans addition of water (By similarity). Plays a role in the metabolism of endogenous lipids such as epoxide-containing fatty acids (PubMed:22798687). Metabolizes the abundant endocannabinoid 2-arachidonoylglycerol (2-AG) to free arachidonic acid (AA) and glycerol (PubMed:24958911). Binds 20(S)-hydroxycholesterol (20(S)-OHC) (By similarity).
EPHX, EPOX, EPHX1, Epoxide hydrolase 1, Epoxide hydratase, Microsomal epoxide hydrolase, mEH
Rabbit Polyclonal Epoxide hydrolase antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human EPHX1 aa 50-300.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 10% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
Epoxide hydrolase also known as EH or EPHX is an enzyme that catalyzes the conversion of epoxides to dihydrodiols. This reaction is important for detoxifying harmful compounds making epoxide hydrolase an important player in maintaining cellular health. The enzyme typically has a molecular mass around 53 kDa. Epoxide hydrolase is expressed in various tissues with significant activity observed in the liver where it contributes to the metabolism of xenobiotics. Alternate forms such as epoxide hydrolase 2 also exist each with specific functions and expression patterns.
The enzyme aids in the metabolic processing of xenobiotic and endogenous epoxides reducing their potential toxicity. Epoxide hydrolase operates by hydrolyzing epoxide substrates which can be harmful if accumulated. The enzyme is not part of a known permanent complex but interacts transiently with various substrates. Its biological role extends to maintaining the equilibrium between pro-inflammatory and anti-inflammatory mediators due to its influence on lipid epoxide metabolism.
Epoxide hydrolase plays a role in the arachidonic acid metabolic pathway where it converts epoxide intermediates into more polar diols. This action regulates the balance of eicosanoids lipid signaling molecules vital for inflammation and immune responses. The enzyme also functions alongside other detoxification enzymes such as cytochrome P450s to facilitate the biotransformation of a wide array of compounds including pharmaceutical agents.
Epoxide hydrolase is linked to several conditions. Polymorphisms in the gene encoding epoxide hydrolase have associations with susceptibility to various cancers due to altered detoxification capacities. Abnormalities in enzyme activity are also associated with cardiovascular diseases as epoxide hydrolase regulates lipid mediators that modulate blood pressure and vascular tone. In these contexts the enzyme’s regulatory role intersects with proteins involved in inflammation and vascular biology like cytochrome P450s and vascular endothelial growth factor (VEGF) influencing disease progression and treatment outcomes.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Gel conc 10% (SDS PAGE)
All lanes: Western blot - Anti-Epoxide hydrolase antibody (ab96774) at 1/1000 dilution
Lane 1: H1299 whole cell lysate at 30 µg
Lane 2: HeLa whole cell lysate at 30 µg
Predicted band size: 53 kDa
Immunohistochemical analysis of paraffin-embedded SG xenograft, using ab96774 at 1/100 dilution.
Immunofluorescence analysis of methanol fixed HeLa, using ab96774 at 1/200 dilution (top image) and costained with Hoescht 33342 (bottom image).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com